US Surpasses Grim 100,000 Coronavirus Death Toll, Lifting of Restrictions Will Still Continue

Despite lockdown measures being lifted around the country and non-essential businesses beginning to open their doors, the coronavirus death toll continues to rise to alarming levels within the United States.

According to the most recent data from John Hopkins University, the coronavirus outbreak in the US is among the world’s deadliest. The US has now surpassed 100,000 deaths, and accounts for 30% of the world’s total infected cases. However, that does not seem to be of concern to President Donald Trump, who is strongly pushing for the reopening of states in favor of preserving the economy.

In the meantime, unemployment numbers in the US have reached over 38.6 million in just a span of over two months. In addition, the GDP level fell by 4.8% since the beginning of the year, making the first quarter of 2020 the largest economic contraction since the 2008 financial crisis.


Information for this briefing was found via CNBC, John Hopkins University, and US Department of Labour. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

How to Still Find 10-Bagger Gold and Silver Stocks | Don Durrett

First Majestic Silver: Jerritt Canyon Is BACK!

Canada May Finally Be Backing Its Battery Supply Chain | John Passalacqua – First Phosphate

Recommended

Antimony Resources Expands Footprint as Soil Sampling Lights Up Ground South of Bald Hill

Mercado Drills 256 g/t Silver Over 6.5 Metres In First Drill Hole of Inaugural Program

Related News

Gilead’s Antiviral Drug Fails to Treat Coronavirus, Preliminary Study Shows

Gilead Sciences Inc (NASDAQ: GILD) has been running a randomized clinical trial on the experimental...

Thursday, April 23, 2020, 04:16:38 PM

Revive Announces Timeline For Phase 3 Studies, Sees Beneficial Psilocybin Developments

Revive Therapeutics (CSE: RVV) this morning announced that on the heels of receiving FDA approval...

Wednesday, August 5, 2020, 09:50:58 AM

Fitch Ratings Anticipating Historic Loan Defaults for April

Since the onset of economic shutdowns across the US, millions of workers have found themselves...

Saturday, April 25, 2020, 12:00:00 PM

Datametrex Secures Rights To Sell And Distribute Rapid COVID-19 Antigen Test Kits

Datametrex AI (TSXV: DM) this morning announced that it has secured the rights to sell...

Wednesday, August 12, 2020, 09:27:09 AM

Revive Files Clinical Trial Application With Health Canada, Releases Phase 3 FDA Study Design For Potential Treatment Of COVID-19

Revive Therapeutics (CSE: RVV) continues to advance its clinical trial efforts. The company announced this...

Wednesday, June 3, 2020, 11:30:38 AM